Benzylpenicilloyl-polylysine | hsa00730 | Thiamine metabolism | 3.09E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
Benzylpenicilloyl-polylysine | hsa01523 | Antifolate resistance | 4.33E-02 | 3 | P41439, P41440, P01375 | FOLR3, SLC19A1, TNF | More | |
Benzylpenicilloyl-polylysine | hsa03013 | RNA transport | 3.51E-03 | 12 | O14980, P52298, P61326, Q7Z3B4, P35658, P47813, Q14152, O75822, Q14240, Q9Y6A5, Q06787, P51114 | XPO1, NCBP2, MAGOH, NUP54, NUP214, EIF1AX, EIF3A, EIF3J, EIF4A2, TACC3, FMR1, FXR1 | More | |
Benzylpenicilloyl-polylysine | hsa04071 | Sphingolipid signaling pathway | 4.05E-02 | 6 | Q9H228, P01375, Q13362, Q9BX95, Q16539, Q9UQC2 | EDG8, TNF, PPP2R5C, SGPP1, MAPK14, GAB2 | More | |
Benzylpenicilloyl-polylysine | hsa04145 | Phagosome | 1.75E-02 | 2 | P08637, O75015 | FCGR3A, FCGR3B | More | |
Benzylpenicilloyl-polylysine | hsa04380 | Osteoclast differentiation | 5.16E-03 | 2 | P08637, O75015 | FCGR3A, FCGR3B | More | |
Benzylpenicilloyl-polylysine | hsa04613 | Neutrophil extracellular trap formation | 7.84E-03 | 2 | P08637, O75015 | FCGR3A, FCGR3B | More | |
Benzylpenicilloyl-polylysine | hsa04622 | RIG-I-like receptor signaling pathway | 4.49E-02 | 1 | P10145 | IL8 | More | |
Benzylpenicilloyl-polylysine | hsa04650 | Natural killer cell mediated cytotoxicity | 5.16E-03 | 2 | P08637, O75015 | FCGR3A, FCGR3B | More | |
Benzylpenicilloyl-polylysine | hsa04657 | IL-17 signaling pathway | 2.75E-02 | 6 | O00463, Q16539, P49841, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, MMP9, LCN2, TNF | More | |
Benzylpenicilloyl-polylysine | hsa04666 | Fc gamma R-mediated phagocytosis | 8.85E-03 | 2 | P08637, O75015 | FCGR3A, FCGR3B | More | |
Benzylpenicilloyl-polylysine | hsa05140 | Leishmaniasis | 6.89E-03 | 2 | P08637, O75015 | FCGR3A, FCGR3B | More | |
Benzylpenicilloyl-polylysine | hsa05144 | Malaria | 2.04E-02 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | |
Benzylpenicilloyl-polylysine | hsa05150 | Staphylococcus aureus infection | 5.99E-03 | 2 | P08637, O75015 | FCGR3A, FCGR3B | More | |
Benzylpenicilloyl-polylysine | hsa05152 | Tuberculosis | 2.35E-02 | 2 | P08637, O75015 | FCGR3A, FCGR3B | More | |
Benzylpenicilloyl-polylysine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.41E-02 | 2 | P10145, P62987 | IL8, UBA52 | More | |
Benzylpenicilloyl-polylysine | hsa05219 | Bladder cancer | 4.49E-02 | 1 | P10145 | IL8 | More | |
Benzylpenicilloyl-polylysine | hsa05322 | Systemic lupus erythematosus | 7.84E-03 | 2 | P08637, O75015 | FCGR3A, FCGR3B | More | |